James Joseph Graziano
Directeur des opérations chez AlivaMab Discovery Services LLC
Profil
James Joseph Graziano is currently a Senior Director-Operations at AlivaMab Biologics LLC and a Vice President-Operations at InduPro, Inc. He was previously a Chief Technology Officer at Sevion Therapeutics, Inc. and a Chief Operating Officer at Fabrus, Inc. Graziano received his doctorate degree from The Scripps Research Institute in 2006 and his undergraduate degree from the University of California, Berkeley.
Postes actifs de James Joseph Graziano
| Sociétés | Poste | Début |
|---|---|---|
AlivaMab Discovery Services LLC
 AlivaMab Discovery Services LLC BiotechnologyHealth Technology AlivaMab Discovery Services LLC is a private company that specializes in generating and screening large panels of antibodies to achieve their partners' design goals. AlivaMab Discovery Services is based in San Diego, CA. The company focuses on delivering antibodies that are characterized for function, kinetics, and developability, and engineering for advanced modalities, including multispecifics and cars. The company has experience in antibody drug discovery and development from many of the world's top pharmaceutical companies, including AbbVie, AstraZeneca, Bristol Myers Squibb, Novartis, Pfizer, and Roche/Genentech. The company was founded by John Lippincott, and the CEO is Larry L. Green. | Directeur des opérations | 01/08/2018 |
InduPro, Inc.
 InduPro, Inc. BiotechnologyHealth Technology InduPro, Inc. engages in integrating inherent protein proximity at the cell surface and translates biological insights into transformative therapeutics. The company is based in San Francisco, CA. The company was founded by K. Christopher Garcia. | Directeur des opérations | - |
Anciens postes connus de James Joseph Graziano
| Sociétés | Poste | Fin |
|---|---|---|
Fabrus, Inc.
 Fabrus, Inc. BiotechnologyHealth Technology Fabrus, Inc. engages in discovering, developing and engineering therapeutic antibodies. It utilizes multiple proprietary product engines that define a new antibody discovery paradigm. The company is headquartered in San Diego, CA. | Directeur des opérations | - |
Sevion Therapeutics, Inc.
 Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de James Joseph Graziano
| University of California, Berkeley | Undergraduate Degree |
| The Scripps Research Institute | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | Commercial Services |
Fabrus, Inc.
Fabrus, Inc. BiotechnologyHealth Technology Fabrus, Inc. engages in discovering, developing and engineering therapeutic antibodies. It utilizes multiple proprietary product engines that define a new antibody discovery paradigm. The company is headquartered in San Diego, CA. | Health Technology |
AlivaMab Discovery Services LLC
AlivaMab Discovery Services LLC BiotechnologyHealth Technology AlivaMab Discovery Services LLC is a private company that specializes in generating and screening large panels of antibodies to achieve their partners' design goals. AlivaMab Discovery Services is based in San Diego, CA. The company focuses on delivering antibodies that are characterized for function, kinetics, and developability, and engineering for advanced modalities, including multispecifics and cars. The company has experience in antibody drug discovery and development from many of the world's top pharmaceutical companies, including AbbVie, AstraZeneca, Bristol Myers Squibb, Novartis, Pfizer, and Roche/Genentech. The company was founded by John Lippincott, and the CEO is Larry L. Green. | Health Technology |
InduPro, Inc.
InduPro, Inc. BiotechnologyHealth Technology InduPro, Inc. engages in integrating inherent protein proximity at the cell surface and translates biological insights into transformative therapeutics. The company is based in San Francisco, CA. The company was founded by K. Christopher Garcia. | Health Technology |
